Correction to: HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging
Crossref DOI link: https://doi.org/10.1007/s00259-024-06792-w
Published Online: 2024-06-20
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Altunay, Betül
Morgenroth, Agnieszka
Beheshti, Mohsen
Vogg, Andreas
Wong, Nicholas C. L.
Ting, Hong Hoi
Biersack, Hans-Jürgen
Stickeler, Elmar
Mottaghy, Felix M.
Text and Data Mining valid from 2024-06-20
Version of Record valid from 2024-06-20
Article History
First Online: 20 June 2024